Description
Eterna Peptides presents premium-grade ARA-290 (20mg) lyophilized powder, an advanced synthetic peptide derived from the structure of erythropoietin (EPO). Specifically engineered as an 11-amino acid fragment, ARA-290 isolates the tissue-protective and regenerative pathways of EPO without stimulating red blood cell production (erythropoiesis).
Mechanism of Action
ARA-290 acts as a highly selective agonist of the Innate Repair Receptor (IRR), a specific cell-surface receptor complex that is upregulated during tissue injury, stress, or inflammation:
* **Innate Repair Activation:** By binding directly to the IRR, it triggers a robust cellular defense system that shuts down the production of pro-inflammatory cytokines.
* **Neuroprotection:** Research highlights its ability to protect peripheral nerve fibers from damage, promoting structural axon repair and long-term functional recovery.
* **Cellular Resilience:** It activates anti-apoptotic (cell-survival) pathways, drastically reducing tissue damage caused by ischemia, oxidative stress, and chronic metabolic stress.
Research Applications
In preclinical and laboratory evaluation, ARA-290 is heavily studied to investigate:
* The reversal and mitigation of peripheral neuropathic pain and small nerve fiber damage.
* Inflammatory modulation in severe autoimmune and chronic metabolic research models.
* Enhanced wound healing, tissue perfusion, and microvascular stabilization.
* Cardioprotective and neuroprotective interventions during acute ischemic events.
Our ARA-290 vials are manufactured under strict quality control standards to ensure optimal structural integrity, reliable reconstitution properties, and precise analytical consistency across all research settings.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
